Shuichi Miyawaki

1PUBLICATIONS
0CO-AUTHORS
Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Feb 07, 2019
Phase II study of FLAGM (fludarabine + high-dose cytarabine + granulocyte colony-stimulating factor + mitoxantrone) for relapsed or refractory acute myeloid leukemia.

Nahoko Hatsumi, Shuichi Miyawaki, Takahiro Yamauchi

Pageof 1

Frequent Collaborators